Summit Therapeutics (SMMT) Enterprise Value (QoQ) (2017 - 2026)
Summit Therapeutics (SMMT) Enterprise Value (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.36% |
| Mar 31, 2026 | 16.08% |
| Dec 31, 2025 | -198.67% |
| Sep 30, 2025 | 19.89% |
| Jun 30, 2025 | -40.76% |
| Mar 31, 2025 | 48.63% |
| Dec 31, 2024 | -338.21% |
| Sep 30, 2024 | -227.25% |
| Jun 30, 2024 | 53.33% |
| Mar 31, 2024 | 13.74% |
| Dec 31, 2023 | 64.10% |
| Sep 30, 2023 | 7.47% |
| Jun 30, 2023 | 11.13% |
| Mar 31, 2023 | 62.70% |
| Dec 31, 2022 | -431.77% |
| Jun 30, 2021 | -1.17% |
| Mar 31, 2021 | -53.88% |
| Dec 31, 2020 | -211.82% |
| Mar 31, 2020 | 8.57% |
| Oct 31, 2019 | 36.36% |